Latest filing published 18 Oct 2018 for Avalo Therapeutics, Inc., €3,564.
Filing timeline
BuySaleInsider track record
Randal Jones: trading record in brief
All filings by Randal Jones on record concern Avalo Therapeutics, Inc. Activity is concentrated on a single trading day, 13 August 2018, with 2 filings.
On the market, this insider has only sold: 1 sale, €4,433 in total. Besides market trades, the filings include 1 option exercise.
The latest filing, published on 18 October 2018, reports an option exercise of €3,564 in Avalo Therapeutics, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Randal Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,270 shares@ US$3.2044.6% of flowCommon StockSEC:0001567619-18-004305:0
- 1,270 shares@ US$3.9855.4% of flowCommon StockSEC:0001567619-18-004305:1
2 of 2 declarations
